1
|
Zhang GF, Rong CM, Li W, Wei BL, Han MT, Han QL. Bilateral carpal tunnel syndrome and motor dysfunction caused by gout and type 2 diabetes: A case report. World J Clin Cases 2023; 11:2535-2540. [PMID: 37123306 PMCID: PMC10131002 DOI: 10.12998/wjcc.v11.i11.2535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Revised: 02/22/2023] [Accepted: 03/15/2023] [Indexed: 04/06/2023] Open
Abstract
BACKGROUND Carpal tunnel syndrome (CTS) has been associated with gout and type 2 diabetes mellitus (T2DM). However, due to insufficient clinical understanding of gout-related CTS and reliance on the diagnostic importance of elevated serum uric acid levels, such cases are prone to missed diagnosis, misdiagnosis, and delayed treatment. In addition, the effect of T2DM on gout - induced carpal tunnel syndrome has not been reported.
CASE SUMMARY Herein, we present an unusual case of CTS and motor dysfunction caused by miliary tophaceous gout and T2DM. The patient presented to the hand and foot clinic with paresthesia of the fingers of both hands, especially at night. The patient was diagnosed with type 2 diabetes a month ago. Ultrasonography revealed bilateral transverse carpal ligament thickening with median nerve compression during hospitalization. The patient was successfully treated with carpal tunnel decompression and tendon release. The postoperative pathological examination revealed typical gout nodules. This case suggests that the presence of T2DM could accelerate tophi formation and worsen CTS symptoms, although no definitive proof in this regard has been described previously.
CONCLUSION Tophi formation may most likely cause the co-occurrence of CTS and flexor dysfunction in gout and incipient diabetes patients.
Collapse
Affiliation(s)
- Gao-Feng Zhang
- Department of Hand and Foot Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong Province, China
| | - Cun-Min Rong
- Department of Hand and Foot Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong Province, China
| | - Wei Li
- Department of Hand and Foot Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong Province, China
| | - Ben-Lei Wei
- Department of Hand and Foot Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong Province, China
| | - Ming-Tong Han
- Department of Hand and Foot Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong Province, China
| | - Qing-Luan Han
- Department of Hand and Foot Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong Province, China
| |
Collapse
|
2
|
Nong Y, Lin JT, Sun XW, Wang J, Ma X, Liu XP, Wang HQ, Zha RT, Shen DP, Jiang SJ, Luo SK, Zhao Q, Meng L, Wang WP, Fang J, Han LM, Lu GB, Zhang W, Li GF, Wang H, Zhao ZY, Zhou W, Wei BL, Yuan YD, Peng LP, Lu XL, Pang GF, Li FH, Li L, Zhen H. [Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]. Zhonghua Yi Xue Za Zhi 2021; 101:205-211. [PMID: 33370867 DOI: 10.3760/cma.j.cn112137-20201122-03166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To observe the efficacy and safety of Kangbingdu granules (KBD) in the treatment of influenza. Methods: A multicenter, randomized, double-blind, double-dummy, and positive-drug parallel control trial was conducted in 27 Grade ⅢA hospitals in China and the subjects were randomly assigned to the KBD test group or the oseltamivir phosphate capsule control group at a ratio of 1∶1. 200 subjects were planned to be enrolled in each group. The experimental group was given KBD (18g each time, 3 times a day) and oseltamivir phosphate simulator orally, while the control group was given oseltamivir phosphate capsule (75 mg each time, twice a day) and KBD simulator orally for 5 days. The primary efficacy indicators included the remission time of major clinical symptoms and the time of complete defervescence. The secondary efficacy indicators included dosage of acetaminophen, the change of traditional Chinese medicine (TCM) syndrome score and the remission time of other important clinical symptoms. The efficacy of KBD in the test group and Oseltamivir phosphate control group were compared. Adverse events or adverse reactions were observed at the same time to evaluate the safety of KBD Granules. Results: A total of 393 subjects from 27 Grade ⅢA hospitals in China were enrolled. The experimental group included 195 subjects and 191 subjects (97.95%) completed the trial, While the control group included 198 subjects and 195 subjects (98.48%) completed the trial. There was no significant difference in the shedding rate and rejection rate between the two groups (P>0.05). In the Full Analysis Set (FAS), the mean age of the experimental group was (34.9±14.4) years old, with 83 males (42.78%). The mean age of the control group was (33.3±13.5) years old, with 78 males (39.59%). There were no statistically significant differences between the two groups in demographic data, physical examination, viral pathogen detection, total score of TCM syndromes and scores of each symptom at baseline (P>0.05). In the FAS, the remission time M (Q1, Q3) of major clinical symptoms was 3.0 (3.0, 4.0) days in the experimental group and 3.0 (3.0, 4.0) days in the control group, and the difference was not statistically significant (P>0.05). The time M (Q1, Q3) of complete defervescence was 34.0 (20.3, 49.0) hours in the experimental group and 36.5 (19.6, 48.8) hours in the control group, and the difference was not statistically significant (P>0.05). KBD granules had the same effect as Oseltamivir phosphate capsule (P>0.05) in terms of acetaminophen dosage, TCM syndrome effect and disappearance rate of most important clinical symptoms. Meanwhile, the disappearance rate of dizziness and chest distress on day 3 in the KBD granules group was better than that of oseltamivir phosphate capsule (P<0.05). Conclusion: KBD granules have the same efficacy as Oseltamivir Phosphate capsule in the treatment of influenza and the drug safety is good.
Collapse
Affiliation(s)
- Y Nong
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - X W Sun
- Department of Lung Diseases, Mudanjiang Hospital of Traditional Chinese Medicine, Mudanjiang 157009, China
| | - J Wang
- Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250001, China
| | - X Ma
- Emergency Department, Luohe Hospital of traditional Chinese Medicine, Luohe 462000, China
| | - X P Liu
- Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Gansu Province, Lanzhou 730030, China
| | - H Q Wang
- Respiratory Department, the Second Affiliated Hospital of Shanxi University of traditional Chinese Medicine, Xianyang 712021, China
| | - R T Zha
- Respiratory Department of Wuhu First people's Hospital, Wuhu 241000, China
| | - D P Shen
- Department of Internal Medicine, Zaozhuang Maternal and Child Health Hospital, Zaozhuang 277800, China
| | - S J Jiang
- Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital, Jinan 250021, China
| | - S K Luo
- Department of Internal Medicine, Urumqi Hospital of Traditional Chinese Medicine, Urumqi 830000, China
| | - Q Zhao
- Department of Respiratory Medicine, Heilongjiang Red Cross (Forest Industry General) Hospital, Haerbin 150040, China
| | - L Meng
- Department of Pulmonary and Critical Care medicine, the Second Affiliated Hospital of Shandong First Medical University, Taian 271000, China
| | - W P Wang
- Department of Respiratory Medicine, Changzhi People's Hospital, Changzhi 046000, China
| | - J Fang
- Department of Respiratory Medicine, Dezhou People's Hospital, Dezhou 253020, China
| | - L M Han
- Department of Respiratory Medicine, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830063, China
| | - G B Lu
- Department of Pulmonary and Critical Care Medicine, Meishan Hospital of Traditional Chinese Medicine, Meishan 620010, China
| | - W Zhang
- Department of Lung Diseases, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China
| | - G F Li
- Respiratory Department of General Hospital of Jizhou Energy Fengfeng Group Co., Ltd, Handan 056011, China
| | - H Wang
- Department of Respiratory Medicine, Mudanjiang First People's Hospital, Mudanjiang 157011, China
| | - Z Y Zhao
- Respiratory Department of Baoding Second Hospital, Baoding 071051, China
| | - W Zhou
- Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan 750003, China
| | - B L Wei
- Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China
| | - Y D Yuan
- Department of Pulmonary and Critical Care Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - L P Peng
- Department of Pulmonary and Critical Care Medicine, the First Hospital of Jilin University, Changchun 130021, China
| | - X L Lu
- Department of Respiratory Medicine, the First Affiliated Hospital of Medical College of Shihezi University, Shihezi 832008, China
| | - G F Pang
- Department of Pulmonary and Critical Care medicine, Affiliated Hospital of Chengde Medical College, Chengde 067000, China
| | - F H Li
- Department of Respiratory Medicine, Weinan Central Hospital, Weinan 714000, China
| | - L Li
- Technical Center for Drug Research and Evaluation of China Association of Traditional Chinese Medicine, Beijing 100101, China
| | - H Zhen
- Technical Center for Drug Research and Evaluation of China Association of Traditional Chinese Medicine, Beijing 100101, China
| |
Collapse
|
4
|
Lai CH, Chen CY, Wei BL, Lee CW. Adsorptive characteristics of cadmium and lead on the goethite-coated sand surface. J Environ Sci Health A Tox Hazard Subst Environ Eng 2001; 36:747-763. [PMID: 11460329 DOI: 10.1081/ese-100103758] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
This study was conducted to develop a heating process for coating crystalline goethite on the sand surface to utilize the adsorbent properties of the coating. Goethite-coated sand was investigated for adsorbing cadmium and lead ions from water by batch and column experiments. Chemical analysis (energy dispersive analysis of X-ray, EDAX) was used for characterizing the cadmium and lead adsorption sites on goethite-coated sand. From the results of the batch experiments, the cadmium and lead ions could be adsorbed effectively on the goethite-coated sand. Maximum adsorption capacity values for cadmium and lead were 319, 704 micrograms-Cd/g-sand and 702, 1241 micrograms-Pb/g-sand at pH = 5.0, pH = 6.0, respectively. The interaction between cadmium, lead ions and goethite on sand surface was primarily to cause the chemical bonding. Results from column experiments indicated that the cadmium and lead ions could be removed higher than 95% before 110, 130 and 66, 85 numbers of pore volume of influent were treated at pH = 5.0 and pH = 6.0, respectively.
Collapse
Affiliation(s)
- C H Lai
- Department of Environmental Engineering and Sanitation, Taiwan, ROC.
| | | | | | | |
Collapse
|
5
|
Wei BL, Brun-Zinkernagel AM, Simecka JW, Prüss BM, Babitzke P, Romeo T. Positive regulation of motility and flhDC expression by the RNA-binding protein CsrA of Escherichia coli. Mol Microbiol 2001; 40:245-56. [PMID: 11298291 DOI: 10.1046/j.1365-2958.2001.02380.x] [Citation(s) in RCA: 304] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Many species of bacteria devote considerable metabolic resources and genetic information to the ability to sense the environment and move towards or away from specific stimuli using flagella. In Escherichia coli and related species, motility is regulated by several global regulatory circuits, which converge to modulate the overall expression of the master operon for flagellum biosynthesis, flhDC. We now show that the global regulator CsrA of E. coli K-12 is necessary for motility under a variety of growth conditions, as a result of its role as an activator of flhDC expression. A chromosomally encoded flhDC'-'lacZ translational fusion was expressed at three- to fourfold higher levels in csrA wild-type strains than in isogenic csrA mutants. Purified recombinant CsrA protein stimulated the coupled transcription-translation of flhDC'-' lacZ in S-30 extracts and bound to the 5' segment of flhDC mRNA in RNA mobility shift assays. The steady-state level of flhDC mRNA was higher and its half-life was approximately threefold greater in a csrA wild-type versus a csrA mutant strain. Thus, CsrA stimulates flhDC gene expression by a post-transcriptional mechanism reminiscent of its function in the repression of glycogen biosynthesis.
Collapse
Affiliation(s)
- B L Wei
- Department of Molecular Biology and Immunology, University of North Texas Health Science Center at Fort Worth, 3500 Camp Bowie Blvd., Fort Worth, TX 76107-2699, USA
| | | | | | | | | | | |
Collapse
|
6
|
Abstract
1,3-Dihydroxy-9,10-anthraquinone (4) was reacted with epichlorohydrin or 1,omega-dibromo-alkane to yield 1-hydroxy-3-(2,3-epoxypropoxy)-9,10-anthraquinone (5) and 1-hydroxy-3-(3-chloro-2-hydroxypropoxy)-9,10-anthraquinone (6) or 1-hydroxy-3-(omega-bromoalkoxy)-9,10-anthraquinone. Ring-opening of the epoxide (5) or 1-hydroxy-3-(omega-bromoalkoxy)-9,10-anthraquinones with appropriate amines, afforded various 1-hydroxy-3-(3-alkylamino-2-hydroxypropoxy)-9,10-anthraquinones. The synthetic compounds were tested in vitro inhibition of human T-24, Hep 3B, Hep G2, SiHa, HT-3, PLC/PRF/5 and 212 cells. Almost all compounds showed significant inhibitory activity against several different cancer cell lines. Structure-activity analysis indicated epoxidation of the hydroxyanthraquinone increased cytotoxicity against tumour cells, but ring-opening of the epoxide group with amine did not enhance the cytotoxic activity. The phosphatidylserine (PS) externalization and DNA fragmentation in SiHa cells were significantly observed after 48 h incubation with selected compound 19. The results show that 19 cause cell death by apoptosis.
Collapse
Affiliation(s)
- B L Wei
- National University Kaohsiung, Kaohsiung, Taiwan, ROC
| | | | | | | | | |
Collapse
|
7
|
Wei BL, Tang H, Kang J, Qu F, Nie ZW. [Changes of auditory brainstem response and auditory cortex response after exposure to intensive noise]. Sheng Li Xue Bao 1994; 46:553-60. [PMID: 7878483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Auditory brainstem response and auditory cortex response were recorded repeatedly in 35 guinea pigs after exposure to intensive white noise (125 dB, 150 min.) for 62 d. the amplitude of evoked potential of acoustic nerve was decreased by 29% (P < 0.05), of the cochlear nuclei by 28% (P < 0.05). However, the amplitude of response of superior olives nuclei was increased by 21% (P < 0.05), of the inferior colliculi by 37% (P < 0.05), of the cortical evoked response by 131% (P < 0.001). The results indicate that the amplitudes of auditory evoked potential showed a centripital augmentation after exposure to intensive noise. The centripital augmentation was observed not only during the period of the temporary threshold shift (TTS) but also during that of the permanent threshold shift (PTS).
Collapse
Affiliation(s)
- B L Wei
- Research Laboratory of Hearing, China Medical University, Shenyang
| | | | | | | | | |
Collapse
|